DDDiego Anibal Dominguez

Diego Anibal Dominguez

*This is an algorithmically generated author record based on publicly available information.

Diego Anibal Dominguez has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Alejandra Weisz

    Central Laboratory National Hospital Prof. Dr. Alejandro Posadas Buenos Aires Argentina

    1 shared publication
  • Carolina Fernandez

    Laboratory of Transfusion‐Transmissible Infections Regional Hemotherapy Center, Prof. Dr. Juan P. Garrahan Hospital Autonomous City of Buenos Aires Argentina

    1 shared publication
  • Claudia Nonaka

    Hemotherapy Service, Department of Diagnosis and Treatment National Hospital Prof. Dr. Alejandro Posadas Buenos Aires Argentina

    1 shared publication
  • Constanza Lapera

    Laboratory of Transfusion‐Transmissible Infections Regional Hemotherapy Center, Prof. Dr. Juan P. Garrahan Hospital Autonomous City of Buenos Aires Argentina

    1 shared publication
  • Giampaolo Scarton

    BIOARS S.A, CABA, Argentina

    1 shared publication
  • Juan Ignacio Degiuseppe

    National Reference Laboratory for Norovirus and Rotavirus National Institute of Infectious Diseases (INEI), ANLIS “Dr. Carlos G. Malbrán Autonomous City of Buenos Aires Argentina

    1 shared publication

Latest Publications

  • Seroprevalence and Associated Factors of Hepatitis A Virus and Hepatitis E Virus Infection Among Blood Donors in Argentina: A Multicentre Study

    by Sara Noemí Vladimirsky, Juan Ignacio Degiuseppe, Lucio Oscar Otegui, Leonardo Sergio Brajterman, Carolina Fernandez, Constanza Lapera, Diego Anibal Dominguez, Alejandra Weisz, Claudia Nonaka, Nancy Rosana Altabert, et al.

    Hepatitis A virus (HAV) and hepatitis E virus (HEV) are enterically transmitted hepatotropic viruses with heterogeneous epidemiological patterns in Argentina. Data simultaneously evaluating both infections in blood donor populations are limited. We conducted a multicentre cross‐sectional study including 848 blood donors from three Argentine blood banks between September 2024 and August 2025. Total antiHAV and antiHEV IgG antibodies were determined by ELISA. Sociodemographic, occupational, dietary, and donation‐related variables were collected using standardized questionnaires. Logistic regression models with restricted cubic splines were applied to assess age‐specific associations and inter‐centre variability. Overall antiHAV seroprevalence was 62.9% (95% CI: 59.6–66.0) and antiHEV seroprevalence was 12.1% (95% CI: 10.1–14.5), with significant differences between blood banks. AntiHAV seropositivity showed a non‐linear association with age and a significant interaction with blood bank ( p < 0.001), whereas no independent associations with questionnaire‐derived exposures were identified after adjustment. AntiHEV seropositivity was not associated with age but remained independently associated with occupational food handling (aOR 1.94; 95% CI: 1.04–3.51) and game meat consumption (aOR 2.19; 95% CI: 1.24–3.81). Dual seropositivity (6.5%) was consistent with statistical independence between infections. AntiHAV and antiHEV seroprevalence in this accessible adult donor population provides updated epidemiological information from three Argentine blood banks. The study also adds data on joint seroprevalence and associated factors, contributing to the understanding of HAV and HEV exposure patterns in this setting.

  • Low-cost and simple PCR process for access to molecular diagnosis of HTLV-1/2 in low-resource countries

    by Nicolás Ducasa, Diego Domínguez, Paula Benencio, Laura Alfie, Patricia Etcheves, Giampaolo Scarton, Mirna Biglione, Mariela Caputo